Phase 2 Readout~quarter
Phase 2 Readout: lasme-cel
- Company
- Cellectis S.A. (CLLS)
- Drug
- lasme-cel
- Indication
- r/r B-ALL
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Get real-time alerts, AI-powered analysis, and full catalyst coverage.